Universal reference book for medicines
Product name: CEREBROLYSAT (CEREBROLYSAT)

Active substance: comb.
drug
Type: Nootropic preparation

Producer: NGO MIKROGEN (Russia)
Composition, form of production and packaging
Solution for the / m introduction
1 amp.

cattle hydrolyzate 1 ml

ampoules of dark glass (5) - packings, cellular outline (1) - packs of cardboard.

ampoules of dark glass (5) - contour plastic packaging (2) - cardboard packs.

ampoules of dark glass (5) - pallets (2) - cardboard packs.

ampoules of dark glass (10) - packs of cardboard.

ampoules (10) - packs of cardboard.

ampoules of dark glass (10) - packings, cellular outline (1) - packs of cardboard.

ampoules of dark glass (10) - packings, cellular outline (2) - packs cardboard.

INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2010.

PHARMACHOLOGIC EFFECT

Cerebrolysate is a preparation of the brain tissue, contains amino acids and biologically active peptides that penetrate the blood-brain barrier and directly enter the nerve cells.
Cerebrolysate improves metabolic processes in the brain cells, activates the synthesis of proteins in neurons, increases the resistance of brain tissue to intoxication, hypoxia, hypoglycemia; improves the state of regulatory mechanisms and bioelectrical activity of the brain, increases the reserve compensatory possibilities of cerebral hemodynamics. All this leads to a decrease in the severity of the neurological deficit.
INDICATIONS

- as part of the complex therapy of cerebrovascular insufficiency (dyscirculatory encephalopathy;

- ischemic stroke (acute phase and stage of rehabilitation);

- condition after hemorrhagic stroke;

- Traumatic brain injury (concussion, craniocerebral trauma, condition after surgical intervention on the brain);

- encephalopathy of different genesis;

- Myelopathy;

- Neuropathy;

- radiculopathy of various genesis (infectious, toxic, traumatic);

- cerebral palsy;

- reduced concentration in children.

DOSING MODE

Intramuscularly administered 1-5 ml daily or every other day.
The course of treatment is 20 injections.
After a 3-6 month break, treatment with cerebrolysates can be repeated (after consulting a doctor).

In neuropediatric practice - intramuscularly, 1-2 ml (up to 1 ml per 10 kg body weight) for 10-15 days, with a repetition of the course 2-3 times a year.

SIDE EFFECT

Injections of the drug in some cases cause local soreness, irritation, flushing.
Possible allergic reactions, increased blood pressure (with concomitant arterial hypertension).
CONTRAINDICATIONS

- severe renal dysfunction;

- status epilepticus;

- Pregnancy;

hypersensitivity.

With caution: the drug is prescribed during lactation.

PREGNANCY AND LACTATION

Contraindicated in pregnancy.
With caution: the drug is prescribed during lactation.
APPLICATION FOR FUNCTIONS OF THE LIVER

Contraindicated in severe impairment of kidney function.

SPECIAL INSTRUCTIONS

With caution should prescribe the drug for allergic diathesis, epilepsy.

OVERDOSE

At present, no cases of drug overdose have been reported.

DRUG INTERACTION

Simultaneous use of cerebrolysate with antidepressants can cause an increase in their effect.

TERMS OF RELEASE FROM PHARMACY

On prescription.

TERMS AND CONDITIONS OF STORAGE

List B. Keep in a place protected from light and inaccessible to children, at a temperature not exceeding 20 ° С.
Shelf life - 3 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!